Today, investors of Clover Health and wellness (NASDAQ: CLOV) are smiling ear to ear. Although clov stock price stays down greater than 25% year-to-date (YTD), shares of the company are up over 20% today.

Why precisely is Clover Health and wellness trading greater right now?

Over the weekend, it was reported that Clover director Chelsea Clinton had recently bought shares of CLOV stock. The transaction, which happened on March 3, saw Clinton purchase 100,000 shares for an average rate of $2.52 per share. In overall, Clinton’s recent purchase totaled up to $252,530, according to a Type 4 submitted to the united state Stocks and Exchange Commission (SEC).

Why Is CLOV Stock Up Today?
Today, CLOV stock is up in response to Clinton’s purchase, which investors are deeming a positive signal. Oftentimes, director trading activity such as this is essential to track since experts often have a much better sight of a business’s long-lasting growth possibility than retail investors.

So, keeping that in mind, are various other experts of Clover favorable on the firm? In the past year, experts have acquired 2.2 million shares and also offered 22.9 million shares. That’s a web of 20.6 million shares offered. This mass expert selling seems to correlate with CLOV stock’s decrease of greater than 60% over the past one year.

Still, with Clinton’s current acquisition, capitalists are wondering who else is betting big on Clover Health and wellness. Allow’s jump right in.

Who Else Is Betting Big on Clover Wellness?
Since the 4th quarter, 160 institutional financiers own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) boost of 8.8%. During the duration, the complete quantity of shares held by institutional investors likewise boosted from 105.7 million to 129.8 million, up almost 23% QOQ. Let’s take a look at the top 5 institutional shareholders.

Vanguard has 25.9 million shares or 7.65% possession. The company bought 8.8 million shares during Q4.
Greenoaks Resources Partners has 24.8 million shares or 7.34% ownership. The firm marketed 24.8 million shares during Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The firm purchased 2.6 million shares during Q4.
2 Sigma Investments has 6.6 million shares or 1.95% ownership. The firm purchased all 6.6 million shares during Q4.
PNC Financial Provider (NYSE: PNC) possesses 6.4 million shares or 1.88% possession. The company offered 249,850 shares throughout Q4.
Out of the top five investors, 3 funds lowered their placements as well as 2 funds increased their positions. Greenoaks Resources Allies had the most remarkable deal, as the fund marketed regarding 50% of its existing position throughout Q4. 2 Sigma’s 6.6 million share acquisition was additionally remarkable, as the acquisition placed it among the top five investors.